2-溴-2-氯-1,1,1-三氟乙烷

BrCH(Cl)CF₃

197.38

1736947

MFCD00009602

329749984

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Inhalation anesthetic. In an effect believed to be independent of anesthesia, halothane inhibits synthesis of 5-hydroxytryptamine in brain tissue, probably at the tryptophan hydroxylase step.

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sales restrictions may apply.

pharmaceutical primary standard

4.5 psi ( 20 ℃)

USP

n20/D 1.369 (lit.)

50.2 ℃ (lit.)

1.872 g/mL at 25 ℃ (lit.)

pharmaceutical (small molecule)

neat

2-8℃

FC(F)(F)C(Cl)Br

1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H

BCQZXOMGPXTTIC-UHFFFAOYSA-N

human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879), GLRA1(2741), GLRB(2743), KCNK10(54207), KCNK18(338567), KCNK2(3776), KCNK3(3777), KCNK9(51305)

GHS05,GHS07,GHS08

Danger

H315 - H318 - H335 - H360

P201 - P280 - P305 + P351 + P338 + P310 - P308 + P313

Eye Dam. 1 - Repr. 1B - Skin Irrit. 2 - STOT SE 3

Respiratory system

6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK 3